Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 20

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine*

Hukkanen, Janne, Gourlay, Steven G., Kenkare, Saraswati, Benowitz, Neal L.·2005·Clinical Pharmacology & Therapeutics
DOI 10.1016/j.clpt.2004.10.012
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.clpt.2004.10.012

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 74

  1. Mello N. K., 1987, Psychopharmacology (Berl), 93, 8, 10.1007/BF02439579 · DOI
  2. DeBon M., 1995, Addict Behav, 20, 335, 10.1016/0306-4603(94)00070-F · DOI
  3. Snively T. A., 2000, Psychoneuroendocrinology, 25, 677, 10.1016/S0306-4530(00)00018-4 · DOI
  4. O'Hara P., 1989, Addict Behav, 14, 595, 10.1016/0306-4603(89)90001-4 · DOI
  5. Pomerleau C. S., 1992, Psychoneuroendocrinology, 17, 627, 10.1016/0306-4530(92)90021-X · DOI
  6. Allen S. S., 1996, J Subst Abuse, 8, 303, 10.1016/S0899-3289(96)90170-4 · DOI
  7. Allen S. S., 2000, Nicotine Tob Res, 2, 231, 10.1080/14622200050147493 · DOI
  8. Perkins K. A., 2000, J Consult Clin Psychol, 68, 176, 10.1037/0022-006X.68.1.176 · DOI
  9. Allen S. S., 1999, Nicotine Tob Res, 1, 129, 10.1080/14622299050011241 · DOI
  10. Craig D., 1992, Int J Addict, 27, 697, 10.3109/10826089209068761 · DOI
  11. Sellers E. M., 2000, Clin Pharmacol Ther, 68, 35, 10.1067/mcp.2000.107651 · DOI
  12. Tyndale R. F., 2002, Ther Drug Monit, 24, 163, 10.1097/00007691-200202000-00026 · DOI
  13. Benowitz N. L., 1994, Clin Pharmacol Ther, 56, 483, 10.1038/clpt.1994.169 · DOI · Paper page
  14. Benowitz N. L., 1994, J Pharmacol Exp Ther, 268, 296
  15. Nakajima M., 1996, Drug Metab Dispos, 24, 1212
  16. Nakajima M., 1996, J Pharmacol Exp Ther, 277, 1010
  17. Dempsey D., 2002, J Pharmacol Exp Ther, 301, 594, 10.1124/jpet.301.2.594 · DOI · Paper page
  18. Rebagliato M., 1998, Am J Obstet Gynecol, 178, 568, 10.1016/S0002-9378(98)70440-5 · DOI
  19. Selby P., 2001, Ther Drug Monit, 23, 189, 10.1097/00007691-200106000-00001 · DOI
  20. Benowitz N. L., 2004, Clin Pharmacol Ther, 75, P36, 10.1016/j.clpt.2003.11.135 · DOI
  21. Zeman M. V., 2002, J Womens Health Gend Based Med, 11, 147, 10.1089/152460902753645281 · DOI
  22. Pickworth W. B., 1998, Psychoneuroendocrinology, 23, 131, 10.1016/S0306-4530(97)00075-9 · DOI
  23. Goldstein D. S., 1983, Am J Obstet Gynecol, 146, 824, 10.1016/0002-9378(83)91086-4 · DOI
  24. Cooke W. H., 2002, Clin Sci (Lond), 102, 639, 10.1042/cs1020639 · DOI
  25. Jacob P., 1991, Biol Mass Spectrom, 20, 247, 10.1002/bms.1200200503 · DOI
  26. Jacob P., 2002, Drug Metab Rev, 34, 160
  27. Gourlay S. G., 1997, Clin Pharmacol Ther, 62, 453, 10.1016/S0009-9236(97)90124-7 · DOI
  28. Lee B. L., 1987, Clin Pharmacol Ther, 41, 474, 10.1038/clpt.1987.59 · DOI
  29. Kashuba A. D., 1998, Clin Pharmacokinet, 34, 203, 10.2165/00003088-199834030-00003 · DOI
  30. McLean C., 2002, J Appl Physiol, 93, 1471, 10.1152/japplphysiol.00762.2000 · DOI
  31. Matsuki S., 1999, J Clin Pharmacol, 39, 1256, 10.1177/00912709922012060 · DOI
  32. Kashuba A. D., 1998, Clin Pharmacol Ther, 63, 540, 10.1016/S0009-9236(98)90105-9 · DOI
  33. Bruguerolle B., 1990, Eur J Clin Pharmacol, 39, 59, 10.1007/BF02657059 · DOI
  34. Balogh A., 1987, Zentralbl Gynakol, 109, 1135
  35. Nagata K., 1997, J Allergy Clin Immunol, 100, 39, 10.1016/S0091-6749(97)70192-1 · DOI
  36. Meyer M. C., 2001, Pharm Res, 18, 394, 10.1023/A:1011075502215 · DOI
  37. Backstrom T., 1979, Acta Neurol Scand, 59, 63, 10.1111/j.1600-0404.1979.tb02912.x · DOI
  38. Rosciszewska D., 1986, J Neurol Neurosurg Psychiatry, 49, 47, 10.1136/jnnp.49.1.47 · DOI
  39. Shavit G., 1984, Neurology, 34, 959, 10.1212/WNL.34.7.959 · DOI
  40. Kumar N., 1988, Epilepsia, 29, 155, 10.1111/j.1528-1157.1988.tb04412.x · DOI
  41. Kim M. J., 2002, Clin Pharmacol Ther, 72, 192, 10.1067/mcp.2002.126174 · DOI
  42. McCune J. S., 2001, J Clin Pharmacol, 41, 723, 10.1177/00912700122010627 · DOI
  43. Labbe L., 2000, Pharmacogenetics, 10, 425, 10.1097/00008571-200007000-00006 · DOI
  44. Kashuba A. D., 1998, Pharmacogenetics, 8, 403, 10.1097/00008571-199810000-00005 · DOI
  45. Gerdin E., 1992, Br J Clin Pharmacol, 34, 250, 10.1111/j.1365-2125.1992.tb04132.x · DOI
  46. Llerena A., 1996, Eur J Drug Metab Pharmacokinet, 21, 129, 10.1007/BF03190261 · DOI
  47. Hogstedt S., 1985, Clin Pharmacol Ther, 37, 688, 10.1038/clpt.1985.114 · DOI
  48. Wadelius M., 1997, Clin Pharmacol Ther, 62, 400, 10.1016/S0009-9236(97)90118-1 · DOI
  49. McAuley J. W., 1999, J Clin Psychopharmacol, 19, 233, 10.1097/00004714-199906000-00006 · DOI
  50. Kirkwood C., 1991, Clin Pharmacol Ther, 50, 404, 10.1038/clpt.1991.157 · DOI
  51. Kharasch E. D., 1999, J Clin Pharmacol, 39, 275, 10.1177/00912709922008290 · DOI
  52. Kashuba A. D., 1998, Clin Pharmacol Ther, 64, 269, 10.1016/S0009-9236(98)90175-8 · DOI
  53. Kamimori G. H., 2000, J Clin Pharmacol, 40, 739, 10.1177/00912700022009495 · DOI
  54. Kharasch E. D., 1997, Anesthesiology, 87, 26, 10.1097/00000542-199707000-00005 · DOI
  55. Kashuba A. D., 1999, Pharmacogenetics, 9, 453
  56. Shah A. K., 2001, J Clin Pharmacol, 41, 1339, 10.1177/00912700122012922 · DOI
  57. Lin Y., 1999, J Clin Pharmacol, 39, 578, 10.1177/00912709922008182 · DOI
  58. Burstein A. H., 1998, Pharmacotherapy, 18, 1271, 10.1002/j.1875-9114.1998.tb03147.x · DOI
  59. Zhu B., 2003, Br J Clin Pharmacol, 55, 264, 10.1046/j.1365-2125.2003.01728.x · DOI
  60. Sarkar M. A., 2003, Drug Metab Dispos, 31, 1, 10.1124/dmd.31.1.1 · DOI
  61. Burk O., 2002, J Biol Chem, 277, 24280, 10.1074/jbc.M202345200 · DOI
  62. Altemus M., 2001, J Clin Endocrinol Metab, 86, 2525, 10.1210/jcem.86.6.7596 · DOI
  63. De Souza M. J., 1991, J Appl Physiol, 70, 2378, 10.1152/jappl.1991.70.6.2378 · DOI
  64. Seki K., 1989, Gynecol Obstet Invest, 27, 201, 10.1159/000293656 · DOI
  65. Genazzani A. R., 1975, J Clin Endocrinol Metab, 41, 431, 10.1210/jcem-41-3-431 · DOI
  66. Burns J. K., 1975, J Physiol, 249, 36P
  67. Stewart P. M., 1993, Clin Endocrinol (Oxf), 38, 387, 10.1111/j.1365-2265.1993.tb00519.x · DOI
  68. Hassan A. A., 1990, Clin Sci (Lond), 78, 39, 10.1042/cs0780039 · DOI
  69. Zevin S., 2000, Clin Pharmacol Ther, 68, 58, 10.1067/mcp.2000.108066 · DOI
  70. Fattinger K., 1997, J Pharmacol Exp Ther, 281, 1238
  71. Benowitz N. L., 1990, J Pharmacol Exp Ther, 254, 1000
  72. Andersson K., 2001, Int J Obes Relat Metab Disord, 25, 1225, 10.1038/sj.ijo.0801654 · DOI · Paper page
  73. Stalke J., 1992, Clin Investig, 70, 218
  74. Newhouse P. A., 1990, Psychoneuroendocrinology, 15, 471, 10.1016/0306-4530(90)90070-P · DOI

Cited by

See all 20

Metadata

Authors
Hukkanen, J., Gourlay, S. G., Kenkare, S., & Benowitz, N. L.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2005-03
Volume
77
Issue
3
Pages
159-169
ISSN
  • 0009-9236
  • 1532-6535
DOI
10.1016/j.clpt.2004.10.012
Cited by
20
References
7

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine*. https://app.cochat.ai/papers/10.1016/j.clpt.2004.10.012
The paper
Hukkanen, J., Gourlay, S. G., Kenkare, S., & Benowitz, N. L. (2005). Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine*. Clinical Pharmacology & Therapeutics. https://doi.org/10.1016/j.clpt.2004.10.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.